ACPE Number: 0217-9999-22-033-H04-P
Pre-Sale Date: N/A
Content Release Date: 05/18/2022
Expiration Date: 05/16/2023
Activity Type: Application-based
CE Credits: 5.0 hours (BPS and ACPE)
Activity Fee: $175 (ASHP member); $275 (non-member)
This course is intended for BCACPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS) to provide an overview of recent standards and guidelines that specialists should be familiar with in practice.
This online activity is approved for 5.0 hours of continuing pharmacy education credit and/or recertification credit.
The American College of Clinical Pharmacy (ACCP) and the American Society of Health-System Pharmacists (ASHP) are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The target audience for this course is the pharmacist with an interest in statistics and trial design and for the pharmacist wishing to earn recertification credit in Ambulatory Care Pharmacy.
Board certified pharmacists are eligible to receive up to 5.0 hours of recertification credit for completing this workshop. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
This course is not intended for those preparing to take the BPS Ambulatory Care Pharmacy Specialty Examination for Certification. To prepare for the examination, please see courses here: http://elearning.ashp.org/catalog/amb-care-review.
This activity is part of the ACCP and ASHP professional development program for BCACP recertification approved by the BPS.
For full program information, please visit: http://elearning.ashp.org/catalog/amb-care-recert
Contact Hours (ACPE and BPS)
Assessment Pass Point
Fundamentals of Biostatistics and Clinical Trial Design Workshop, 2022 Edition (Cert # L229134)
After participating in this CPE activity, learners should be able to:
- Delineate the key attributes of study variables (data) and the primary levels/categories of data measurement (give examples of each). Develop examples of converting data from one level/category to another.
- Define the two primary types of errors possible when statistically interpreting and making inferences on data being compared.
- Define and interpret a p value and confidence intervals, including the concept of statistical significance, for both absolute and relative comparison values.
- Define the difference between independent and paired (repeated measures) data measurements and comparisons.
- Select the most appropriate statistical test given the type/level of data measurement assessed and given the research question being addressed in a study.
- Differentiate and recognize the designs and structures of key studies utilized in medical publications.
- Define and interpret key study-related concepts and terms.
- Describe and calculate the most important epidemiological terms associated with healthcare and research.
- Describe and calculate the key terms associated with healthcare screenings.
Larry W. Segars, Pharm.D., DrPH, FCCP, FACE, BCPS, RPh
Associate Professor of Pharmacology & Biosciences
College of Osteopathic Medicine & College of Bioscience
Kansas City University of Medicine and Biosciences
Kansas City, Missouri
Mate M. Soric, Pharm.D., FCCP, BCPS
Chair and Professor
Department of Pharmacy Practice
Northeast Ohio Medical University College of Pharmacy
Clinical Pharmacy Specialist, Internal Medicine
University Hospitals Geauga Medical Center
Sarah L. Anderson, Pharm.D., FASHP, FCCP, BCACP, BCPS
Jamie A. Foushee, Pharm.D., BCCCP
Bernard R. Lee, Pharm.D., BCPS, BCPPS
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity’s content have relevant financial relationships:
- Dr. Larry Segars: Speaker, Ascendis Pharmaceuticals, Inc.
- Dr. Sarah Anderson: Stock, Abbott Laboratories, Becton Dickinson, Johnson & Johnson, Merck
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As required by the Standards of Integrity and Independence in Accredited Continuing Education, all relevant financial relationships have been mitigated prior to the CPE activity.
This activity consists of audio and slides, a PDF book chapter, an attestation statement, and an activity evaluation. Learners must review all content and complete the attestation statement and evaluation to receive continuing pharmacy education credit for the activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
These activities were developed by ACCP and ASHP.